Identifying different types of lung cancer using advanced data analysis
Leveraging Heterogenous Common Fund Data Sets and Beyond for Identifying Lung Cancer Subtypes
['FUNDING_R03'] · UNIVERSITY OF NEBRASKA MEDICAL CENTER · NIH-10990280
This study is looking to make it easier to identify different types of lung cancer by using advanced technology to analyze a lot of biological information, which could help doctors provide more personalized treatment options for patients.
Quick facts
| Phase | ['FUNDING_R03'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF NEBRASKA MEDICAL CENTER (nih funded) |
| Locations | 1 site (OMAHA, UNITED STATES) |
| Trial ID | NIH-10990280 on ClinicalTrials.gov |
What this research studies
This research aims to improve the identification of lung cancer subtypes by integrating various types of biological data, including genomic and epigenetic information. By utilizing advanced machine learning techniques, the project seeks to analyze large datasets generated from multiple sources, which can lead to more accurate and efficient subtype classification. This approach aims to overcome the limitations of traditional methods that are often costly and time-consuming. Patients may benefit from more personalized treatment options based on their specific lung cancer subtype.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with lung cancer, particularly those with non-small cell lung cancer or small cell lung cancer.
Not a fit: Patients with lung cancer who do not have identifiable subtypes or those with other unrelated cancers may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more precise and tailored treatment strategies for lung cancer patients.
How similar studies have performed: Previous research has shown promise in using integrated data approaches for cancer subtype identification, indicating potential success for this novel methodology.
Where this research is happening
OMAHA, UNITED STATES
- UNIVERSITY OF NEBRASKA MEDICAL CENTER — OMAHA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WAN, SHIBIAO — UNIVERSITY OF NEBRASKA MEDICAL CENTER
- Study coordinator: WAN, SHIBIAO
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Cause, Cancer Etiology, Cancers